US Patent 11098368 ALK and NTRK1 fusion molecules and uses thereof

Patent 11098368 was granted and assigned to Foundation Medicine on August, 2021 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Foundation Medicine

Current Assignee

Foundation Medicine

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

110983680

Patent Inventor Names

Roman Yelensky0

Doron Lipson0

Maureen T. Cronin0

Date of Patent

August 24, 2021

Patent Application Number

201805140

Date Filed

May 14, 2018

Patent Citations Received

‌

US Patent 11771698 Methods of treating cholangiocarcinoma

‌

US Patent 11578372 NTRK1 fusion molecules and uses thereof

Patent abstract

Novel ALK and NTRK1 fusion molecules and uses are disclosed.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11098368 ALK and NTRK1 fusion molecules and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API